CompanyGraph
Beijing Centergate Technologies (Holding) Co. Ltd.
000931 · SZSE · China
centek.com.cnFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionP/E ratio is 217×, higher than 95% of its Medical Instruments & Supplies peers (median 30.34×)
- FinancialsAltman Z-Score 1.88: grey zone
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.47%
Annual Rate
CNY 0.02Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.23BCNY479.14M · vs all stocks (USD)
Trailing P/E
217.00xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.30BCNY340.95M · vs all stocks (USD)
Profit Margin
0.69%vs Medical Instruments & Supplies peers
Beta
0.2660xvs all stocks
52-Week Change
-21.57%vs all stocks
Forward Annual Dividend Yield
0.47%vs all stocks
Market Capitalization
3.23BCNY479.14M · vs all stocks (USD)
Enterprise Value
4.40BCNY651.80M · vs all stocks (USD)
Trailing P/E
217.00xvs Medical Instruments & Supplies peers
PEG Ratio
-1.07xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.42xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.02xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.91xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
18.26xvs Medical Instruments & Supplies peers
Gross Margin
49.61%vs Medical Instruments & Supplies peers
Profit Margin
0.69%vs Medical Instruments & Supplies peers
Operating Margin
2.14%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
2.01%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.50%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.30BCNY340.95M · vs all stocks (USD)
Revenue per Share (TTM)
3.06CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-23.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.28BCNY190.00M · vs all stocks (USD)
EBITDA (TTM)
330.33MCNY48.99M · vs all stocks (USD)
Net Income (TTM)
15.87MCNY2.35M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-23.35%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
49.24MCNY7.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
78.47MCNY11.64M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0200CNYUpdated Aug 18, 2026Forward Annual Dividend Yield
0.47%vs all stocks
Trailing Annual Dividend Rate
0.0200CNYUpdated Aug 18, 2026Trailing Annual Dividend Yield
0.47%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
219.87MCNYFY2025 · Dec 31, 2025Revenue
2.44BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
995.34MCNYFY2025 · Dec 31, 2025Gross Profit
1.45BCNYFY2025 · Dec 31, 2025Operating Income
176.90MCNY26.23M · vs all stocks (USD)
Pre-tax Income
105.63MCNYFY2025 · Dec 31, 2025Income Tax Expense
44.21MCNYFY2025 · Dec 31, 2025Net Income
61.42MCNYFY2025 · Dec 31, 2025EBIT
154.67MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
330.33MCNYFY2025 · Dec 31, 2025Research & Development
100.68MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
903.18MCNYFY2025 · Dec 31, 2025Other Operating Expenses
34.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
245.13KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
49.04MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0636CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0636CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
752.92MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
752.92MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
61.42MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-13.54MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
252.80MCNYFY2025 · Dec 31, 2025Free Cash Flow
153.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
133.32MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
61.42MCNYFY2025 · Dec 31, 2025Other Non-cash Items
87.81MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
76.39MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
27.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-99.16MCNYFY2025 · Dec 31, 2025Purchase of Investments
-20.02MCNYFY2025 · Dec 31, 2025Sale of Investments
22.00MCNYFY2025 · Dec 31, 2025Other Investing Activity
3.80KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-97.18MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
551.10MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-468.25MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-4.91MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.26MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
75.69MCNYFY2025 · Dec 31, 2025Shares Outstanding
753.13MSharesUpdated Aug 18, 2026Float Shares
505.99MSharesUpdated Aug 18, 2026% Held by Insiders
35.04%vs all stocks
% Held by Institutions
0.65%vs all stocks
Total Cash (MRQ)
229.31MCNY34.01M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3040CNYUpdated Aug 18, 2026Total Debt (MRQ)
1.20BCNY178.38M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6537xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.17xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
2.15CNYUpdated Aug 18, 2026Total Assets
4.00BCNY593.49M · vs all stocks (USD)
Total Current Assets
1.69BCNYFY2025 · Dec 31, 2025Total Liabilities
2.15BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.31BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
671.86MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.47BCNYFY2025 · Dec 31, 2025Cash
133.32MCNYFY2025 · Dec 31, 2025Cash Equivalents
5.74MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
139.06MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.76MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.04BCNYFY2025 · Dec 31, 2025Inventory
186.94MCNYFY2025 · Dec 31, 2025Accounts Payable
448.26MCNYFY2025 · Dec 31, 2025Short-term Debt
642.64MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.78MCNYFY2025 · Dec 31, 2025Long-term Debt
484.56MCNYFY2025 · Dec 31, 2025Common Stock (Book)
753.13MCNYFY2025 · Dec 31, 2025Retained Earnings
501.62MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.86BCNY275.15M · vs all stocks (USD)
52-Week Low
3.76CNYUpdated Aug 18, 202652-Week High
5.73CNYUpdated Aug 18, 202652-Week Change
-21.57%vs all stocks
Beta
0.2660xvs all stocks
50-Day MA
4.16CNYUpdated Aug 18, 2026200-Day MA
4.80CNYUpdated Aug 18, 2026Avg 10-Day Volume
9.98MSharesUpdated Aug 18, 2026Avg 30-Day Volume
10.04MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
0.0200CNYUpdated Aug 18, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 217×, higher than 95% of its Medical Instruments & Supplies peers (median 30.34×)Significant
P/E ratio: 217Industry median: 30.34Industry P95: 123.965Peers compared: 65.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.50Profit Margin: 0.01
Financial Health
Altman Z-Score 1.88: grey zoneSignificant
Altman Z-Score: 1.88
High earnings qualityNotable
Earnings Quality Score: 2.04
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Genbyte Technology Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Yorhe Fluid Intelligent Control Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
SmartGen Zhengzhou Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Three Stars New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Qatar National Cement Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Miahona Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai SK Petroleum & Chemical Equipment Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Donghong Pipe Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Hollywave Electronic System Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jiangsu Huifeng Bio Agriculture Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Guanhao Biotech Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Book Value
Hangzhou Jiebai Group Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Book Value
Huadian New Energy Group Corporation
3 interpretationsReceivables Heavy and GrowingClose Below 40W SMA With ProfitabilityPrice Below Mean With Profitability And Book Value